Leuko 的设备由麻省理工学院的研究人员开发，无需进行血液检查，即可监测癌症患者化疗期间的健康状况，利用光和人工智能检测白细胞计数低和潜在感染。 Leuko's device, developed by MIT researchers, monitors cancer patients' health during chemotherapy without blood tests, using light and AI to detect low white blood cell counts and potential infections.
由麻省理工学院研究人员创立的美国公司 Leuko 开发了一种设备，可让医生在化疗期间监测癌症患者的健康状况，而无需进行血液检查。 US-based firm Leuko, founded by MIT researchers, has developed a device that allows doctors to monitor cancer patients' health during chemotherapy without the need for blood tests. 该设备利用光线分析指甲顶部，并利用人工智能检测白细胞计数是否处于危险的低水平，帮助医生远程发现癌症患者中危及生命的感染。 The device uses light to analyze the top of the fingernail and artificial intelligence to detect when white blood cell counts are dangerously low, helping doctors spot life-threatening infections in cancer patients remotely.